{"id":30133,"date":"2017-06-01T12:24:19","date_gmt":"2017-06-01T11:24:19","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=30133"},"modified":"2017-06-01T12:24:19","modified_gmt":"2017-06-01T11:24:19","slug":"els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/","title":{"rendered":"Els farmac\u00e8utics actualitzen coneixements en melatonina i dermatitis at\u00f2pica"},"content":{"rendered":"<p>El passat mes d\u2019abril van tenir lloc dues confer\u00e8ncies relacionades amb la dermofarm\u00e0cia i els productes sanitaris: \u201c<strong>Noves formulacions en melatonina per prevenir l&#8217;envelliment i el dany cel\u00b7lular a la pell<\/strong>\u201d (6 d\u2019abril) i \u201c<strong>Nous abordatges en el maneig de la dermatitis at\u00f2pica<\/strong>\u201d (27 d\u2019abril).<\/p>\n<figure id=\"attachment_30136\" aria-describedby=\"caption-attachment-30136\" style=\"width: 298px\" class=\"wp-caption alignright\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2017\/05\/dermofarmacia-abril-cofb-1.jpg\"><img fetchpriority=\"high\" decoding=\"async\" class=\" wp-image-30136   \" title=\"Els farmac\u00e8utics actualitzen coneixements en melatonina i dermatitis at\u00f2pica\" alt=\"dermofarmacia-abril-cofb (1)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2017\/05\/dermofarmacia-abril-cofb-1.jpg\" width=\"298\" height=\"199\" \/><\/a><figcaption id=\"caption-attachment-30136\" class=\"wp-caption-text\">Marta Alcalde, vocal de Dermofarm\u00e0cia i Productes Sanitaris del COFB<\/figcaption><\/figure>\n<p>A la primera confer\u00e8ncia es va abordar l\u2019<strong>envelliment i els efectes de la melatonina a nivell cel\u00b7lular i mitocondrial<\/strong>. <b>Francisca Miranda<\/b>, responsable del Departament de Fabricaci\u00f3 de IUCT, i <b>Germaine Escames<\/b>, directora cient\u00edfica de Pharmamel i catedr\u00e0tica en Fisiologia de la Facultat de Farm\u00e0cia de Granada, van revisar les funcions de la melatonina a la c\u00e8l\u00b7lula per prevenir l\u2019envelliment actuant des del seu interior.<\/p>\n<div class=\"box shadow\">\u201cEscames fa m\u00e9s de 25 anys que estudia els efectes de la melatonina a nivell cel\u00b7lular i mitocondrial i des de la seva experi\u00e8ncia ens va fer una exposici\u00f3 molt t\u00e8cnica on va parlar de tot el proc\u00e9s d\u2019envelliment de les c\u00e8l\u00b7lules i de la pell, i de com la melatonina t\u00e9 uns efectes demostrats com antioxidant, antiinflamatori i protector mitocondrial. <strong>Aquests efectes de la melatonina el fan un actiu molt interessant en processos d\u2019envelliment cutani i tamb\u00e9 per tractar problemes derivats de tractaments oncol\u00f2gics com la mucositis i la radiodermitis<\/strong>\u201d explica <strong>Marta Alcalde, vocal de Dermofarm\u00e0cia i Productes sanitaris del COFB<\/strong>, que va moderar la confer\u00e8ncia.<\/p>\n<p>\u201cA banda dels efectes cosm\u00e8tics contra l\u2019envelliment, aquestes possibles aplicacions m\u00e8diques -un cop superats els diferents estudis cl\u00ednics on es trobaven els productes- <strong>poden ser molt interessants per alleugerir problemes molt molestos pels malalts que pateixen aquestes malalties<\/strong>. Tots aquests estudis d\u2019efic\u00e0cia van venir corroborats Miranda, del Departament de Fabricaci\u00f3 del IUCT, que \u00e9s l\u2019empresa externa que s\u2019ha encarregat de realitzar-los\u201d matisa Alcalde.<\/div>\n<p style=\"text-align: center;\">\u00a0<a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2017\/05\/dermofarmacia-abril-cofb-3.jpg\"><img decoding=\"async\" class=\" wp-image-30138 aligncenter\" title=\"Els farmac\u00e8utics actualitzen coneixements en melatonina i dermatitis at\u00f2pica\" alt=\"dermofarmacia-abril-cofb (3)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2017\/05\/dermofarmacia-abril-cofb-3.jpg\" width=\"616\" height=\"312\" \/><\/a><\/p>\n<p>D\u2019altra banda, la <b><a href=\"http:\/\/www.farmaceuticonline.com\/ca\/familia\/481-dermatitis-atopica\">dermatitis at\u00f2pica<\/a><\/b> \u00e9s una de les patologies dermatol\u00f2giques de consulta m\u00e9s freq\u00fcents a l\u2019oficina de farm\u00e0cia, i per tant el paper del farmac\u00e8utic a l\u2019hora de fer seguiment dels tractaments prescrits i recomanacions d\u2019higiene i hidrataci\u00f3, amb l\u2019objectiu d\u2019alleugerir els s\u00edmptomes i espaiar els brots, \u00e9s molt important.<\/p>\n<figure id=\"attachment_30144\" aria-describedby=\"caption-attachment-30144\" style=\"width: 298px\" class=\"wp-caption alignright\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2017\/05\/dermofarmacia-abril-cofb-formacio-5.jpg\"><img decoding=\"async\" class=\" wp-image-30144 \" title=\"Els farmac\u00e8utics actualitzen coneixements en melatonina i dermatitis at\u00f2pica\" alt=\"dermofarmacia-abril-cofb-formacio (5)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2017\/05\/dermofarmacia-abril-cofb-formacio-5.jpg\" width=\"298\" height=\"199\" \/><\/a><figcaption id=\"caption-attachment-30144\" class=\"wp-caption-text\">Esther Serra-Baldrich (Hospital de Sant Pau de Barcelona)<\/figcaption><\/figure>\n<p><strong>El tractament cosm\u00e8tic de la dermatitis at\u00f2pica es basa en una combinaci\u00f3 d\u2019emol\u00b7lients t\u00f2pics per restaurar la barrera protectora de la pell<\/strong>. Les futures estrat\u00e8gies dermocosm\u00e8tiques contemplen el tractament personalitzat adaptat a la situaci\u00f3 de cada pacient, amb l\u2019objectiu de reduir els efectes secundaris dels tractaments farmacol\u00f2gics i els episodis de brot. A la segona confer\u00e8ncia, es van revisar els diferents abordatges de l\u2019at\u00f2pia i coneixerem l\u2019experi\u00e8ncia cl\u00ednica en la utilitzaci\u00f3 de nous actius com ara el pl\u00e0ncton mar\u00ed.<\/p>\n<div class=\"box shadow\">La confer\u00e8ncia va comptar com a ponents amb l\u2019<b>Esther Serra-Baldrich<\/b>, responsable de la Unitat d\u2019Immunoal\u00e8rgia Cut\u00e0nia de l\u2019Hospital de Sant Pau de Barcelona, que va parlar de la malaltia i els diferents tractaments que hi ha per abordar-la, tant dels cl\u00e0ssics com de les noves mol\u00e8cules com el fitopl\u00e0ncton i de les que en un futur tindrem. \u201cVa donar molta import\u00e0ncia a qu\u00e8 <strong>no hi ha un tractament est\u00e0ndard, sin\u00f3 que s\u2019ha de personalitzar molt en cada pacient<\/strong>, i tamb\u00e9 a qu\u00e8 tots els tractaments s\u00f3n compatibles entre si: com que<strong> la dermatitis at\u00f2pica t\u00e9 una simptomatologia molt variada cada tractament pot servir per atacar un punt en concret per\u00f2 a l\u2019hora tots s\u00f3n complementaris<\/strong>\u201d explica <strong>Alcalde<\/strong>. \u201cLa Dra. en Tecnologia dels Aliments, <b>Pilar Ram\u00edrez<\/b>, va parlar sobre que \u00e9s el fitopl\u00e0ncton mar\u00ed, com s\u2019extreu i quina \u00e9s la seva activitat contra l\u2019estr\u00e8s oxidatiu i per tant com pot ajudar a la regeneraci\u00f3 de la pell, en aquests processos que cursen amb una gran xerosis i descamaci\u00f3\u201d.<\/div>\n<p style=\"text-align: center;\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2017\/05\/dermofarmacia-abril-cofb-formacio-4.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\" wp-image-30143 aligncenter\" title=\"Els farmac\u00e8utics actualitzen coneixements en melatonina i dermatitis at\u00f2pica\" alt=\"dermofarmacia-abril-cofb-formacio (4)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2017\/05\/dermofarmacia-abril-cofb-formacio-4.jpg\" width=\"598\" height=\"318\" \/><\/a><\/p>\n<div class=\"box info\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2017\/06\/AP-poster.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignright  wp-image-30530\" title=\"Els farmac\u00e8utics actualitzen coneixements en melatonina i dermatitis at\u00f2pica\" alt=\"AP-poster\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2017\/06\/AP-poster.jpg\" width=\"325\" height=\"160\" \/><\/a>La <strong>vocal de Dermofarm\u00e0cia del COFB, Marta Alcalde<\/strong>, tamb\u00e9 va presentar una de les tres <strong>Jornades de Psoriasi i Artritis Psori\u00e0sica,<\/strong> que va acollir el Col\u00b7legi el 17 de maig. <a href=\"http:\/\/www.accionpsoriasis.org\/\" target=\"_blank\" rel=\"noopener\">Acci\u00f3 Psoriasi<\/a> commemora en tres ciutats la data del seu naixement, organitzant <strong>trobades informatives en els quals fa arribar la informaci\u00f3 sobre la patologia a pacients i familiars<\/strong>. Les reunions tenen com a objectiu resoldre els dubtes dels assistents, gr\u00e0cies a la participaci\u00f3 d&#8217;especialistes en psoriasi i artritis psori\u00e0sica de cadascuna de les zones en les quals estem presents. <strong>Les jornades s&#8217;organitzen en col\u00b7laboraci\u00f3 amb els Col\u00b7legis Oficials de Farmac\u00e8utics i amb els Col\u00b7legis Oficials d&#8217;Infermeria de les ciutats on se celebren.<\/strong><\/p>\n<p style=\"text-align: left;\" align=\"right\">Propera jornada: <strong>avui a Cadis<\/strong> (1 de juny). M\u00e9s informaci\u00f3 <a href=\"http:\/\/www.accionpsoriasis.org\/actualidad\/628-cadiz-zaragoza-y-barcelona-acogen-nuestras-jornadas-de-mayo.html\" target=\"_blank\" rel=\"noopener\">aqu\u00ed<\/a>. <\/div>\n<p align=\"right\"><b>Amb la col\u00b7laboraci\u00f3 de:<\/b><\/p>\n<p align=\"right\">Confer\u00e8ncia melatonina<\/p>\n<p align=\"right\"><a href=\"http:\/\/pharmamel.com\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignright size-full wp-image-30146\" alt=\"logo-pharmamel\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2017\/05\/logo-pharmamel.jpg\" width=\"108\" height=\"63\" \/><\/a><\/p>\n<p align=\"right\">\n<p align=\"right\">\n<p align=\"right\">Confer\u00e8ncia dermatitis at\u00f2pica<\/p>\n<p align=\"right\"><a href=\"https:\/\/dermoesteticadelsur.com\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignright size-full wp-image-30145\" alt=\"logo-dds\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2017\/05\/logo-dds.jpg\" width=\"108\" height=\"63\" \/><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>El passat mes d\u2019abril van tenir lloc dues confer\u00e8ncies relacionades amb la dermofarm\u00e0cia i els productes sanitaris: \u201cNoves formulacions en melatonina per prevenir l&#8217;envelliment i el dany cel\u00b7lular a la pell\u201d (6 d\u2019abril) i \u201cNous abordatges en el maneig de la dermatitis at\u00f2pica\u201d (27 d\u2019abril). A la primera confer\u00e8ncia es [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":30141,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[57],"tags":[802,209,213,81,707,53,70,2758,237,231],"class_list":["post-30133","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mon-collegial","tag-accio-psoriasi","tag-artritis-psoriasica","tag-dermatitis-atopica","tag-dermofarmacia","tag-envelliment","tag-farmaceutics","tag-formacio","tag-melatonina","tag-productes-sanitaris","tag-psoriasi"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Els farmac\u00e8utics actualitzen coneixements en melatonina i dermatitis at\u00f2pica<\/title>\n<meta name=\"description\" content=\"Els farmac\u00e8utics actualitzen coneixements en melatonina i dermatitis at\u00f2pica\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Els farmac\u00e8utics actualitzen coneixements en melatonina i dermatitis at\u00f2pica\" \/>\n<meta property=\"og:description\" content=\"Els farmac\u00e8utics actualitzen coneixements en melatonina i dermatitis at\u00f2pica\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2017-06-01T11:24:19+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Els farmac\u00e8utics actualitzen coneixements en melatonina i dermatitis at\u00f2pica\",\"datePublished\":\"2017-06-01T11:24:19+00:00\",\"dateModified\":\"2017-06-01T11:24:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/\"},\"wordCount\":863,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"Acci\u00f3 Psoriasi\",\"artritis psori\u00e0sica\",\"dermatitis at\u00f2pica\",\"Dermofarm\u00e0cia\",\"envelliment\",\"farmac\u00e8utics\",\"Formaci\u00f3\",\"melatonina\",\"productes sanitaris\",\"psoriasi\"],\"articleSection\":[\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/\",\"name\":\"Els farmac\u00e8utics actualitzen coneixements en melatonina i dermatitis at\u00f2pica\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2017-06-01T11:24:19+00:00\",\"dateModified\":\"2017-06-01T11:24:19+00:00\",\"description\":\"Els farmac\u00e8utics actualitzen coneixements en melatonina i dermatitis at\u00f2pica\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Els farmac\u00e8utics actualitzen coneixements en melatonina i dermatitis at\u00f2pica\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Els farmac\u00e8utics actualitzen coneixements en melatonina i dermatitis at\u00f2pica","description":"Els farmac\u00e8utics actualitzen coneixements en melatonina i dermatitis at\u00f2pica","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/","og_locale":"ca_ES","og_type":"article","og_title":"Els farmac\u00e8utics actualitzen coneixements en melatonina i dermatitis at\u00f2pica","og_description":"Els farmac\u00e8utics actualitzen coneixements en melatonina i dermatitis at\u00f2pica","og_url":"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2017-06-01T11:24:19+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"4 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Els farmac\u00e8utics actualitzen coneixements en melatonina i dermatitis at\u00f2pica","datePublished":"2017-06-01T11:24:19+00:00","dateModified":"2017-06-01T11:24:19+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/"},"wordCount":863,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/#primaryimage"},"thumbnailUrl":"","keywords":["Acci\u00f3 Psoriasi","artritis psori\u00e0sica","dermatitis at\u00f2pica","Dermofarm\u00e0cia","envelliment","farmac\u00e8utics","Formaci\u00f3","melatonina","productes sanitaris","psoriasi"],"articleSection":["M\u00f3n col\u00b7legial"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/","url":"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/","name":"Els farmac\u00e8utics actualitzen coneixements en melatonina i dermatitis at\u00f2pica","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/#primaryimage"},"thumbnailUrl":"","datePublished":"2017-06-01T11:24:19+00:00","dateModified":"2017-06-01T11:24:19+00:00","description":"Els farmac\u00e8utics actualitzen coneixements en melatonina i dermatitis at\u00f2pica","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Els farmac\u00e8utics actualitzen coneixements en melatonina i dermatitis at\u00f2pica"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"El passat mes d\u2019abril van tenir lloc dues confer\u00e8ncies relacionades amb la dermofarm\u00e0cia i els productes sanitaris: \u201cNoves formulacions en melatonina per prevenir l&#8217;envelliment i el dany cel\u00b7lular a la pell\u201d (6 d\u2019abril) i \u201cNous abordatges en el maneig de la dermatitis at\u00f2pica\u201d (27 d\u2019abril). A la primera confer\u00e8ncia es [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/30133","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=30133"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/30133\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=30133"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=30133"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=30133"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}